{"code":"D64.81","type":"code","title":"Anemia due to antineoplastic chemotherapy","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["refractory anemia (D46.-)","refractory anemia with excess blasts in transformation [RAEB T] (C92.0-)"],"excludes2":["anemia in neoplastic disease (D63.0)","aplastic anemia due to antineoplastic chemotherapy (D61.1)"],"isBillable":true,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":true,"billableFy2027":true},"inclusionTerms":["Antineoplastic chemotherapy induced anemia"],"useAdditionalCode":[],"clinicalDefinition":"Anemia due to antineoplastic chemotherapy is a billable ICD-10-CM diagnosis code (D64.81). Inclusion terms: Antineoplastic chemotherapy induced anemia. Excludes1 (not coded here): refractory anemia (D46.-); refractory anemia with excess blasts in transformation [RAEB T] (C92.0-). Excludes2 (not included here): anemia in neoplastic disease (D63.0); aplastic anemia due to antineoplastic chemotherapy (D61.1).","officialDefinition":"Anemia due to antineoplastic chemotherapy is a billable ICD-10-CM diagnosis code (D64.81). Inclusion terms: Antineoplastic chemotherapy induced anemia. Excludes1 (not coded here): refractory anemia (D46.-); refractory anemia with excess blasts in transformation [RAEB T] (C92.0-). Excludes2 (not included here): anemia in neoplastic disease (D63.0); aplastic anemia due to antineoplastic chemotherapy (D61.1).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}